OCSAW

Oculis Holding

• Benzinga·03/31 08:10

  Oculis Receives European Medicines Agency PRIME Designation For Privosegtor In Optic Neuritis, Accelerating PIONEER Registrational Program Across Three Global Trials

• TipRanks·03/17 12:36

  Three new option listings on March 17th

• Dow Jones·03/05 12:38

  Oculis Holding Price Target Raised to $50.00/Share From $40.00 by Stifel

• Dow Jones·03/05 12:38

  Oculis Holding Is Maintained at Buy by Stifel

• Benzinga·03/05 12:27

  Stifel Maintains Buy on Oculis Holding, Raises Price Target to $50

• TipRanks·03/05 12:20

  Analysts Are Bullish on These Healthcare Stocks: BillionToOne, Inc. Class A (BLLN), Concentra Group Holdings Parent, Inc. (CON)

• TipRanks·03/05 12:01

  Analysts’ Top Healthcare Picks: Oculis Holding (OCS), AnaptysBio (ANAB)

• TipRanks·03/05 11:47

  Oculis price target raised to $50 from $40 at Stifel

• TipRanks·03/04 22:10

  Oculis Files 2025 Financials and Renews $100 Million ATM Program

• TipRanks·03/04 21:25

  Oculis files automatic mixed securities shelf

• Dow Jones·03/04 17:10

  Oculis Holding Price Target Raised to $44.00/Share From $42.00 by HC Wainwright & Co.

• Dow Jones·03/04 17:10

  Oculis Holding Is Maintained at Buy by HC Wainwright & Co.

• TipRanks·03/04 17:05

  Oculis price target raised to $44 from $42 at H.C. Wainwright

• TipRanks·03/04 17:05

  Oculis: Advancing Late-Stage Ophthalmology Pipeline Drives Upside and Supports Buy Rating

• Benzinga·03/04 17:02

  HC Wainwright & Co. Maintains Buy on Oculis Holding, Raises Price Target to $44